Jane Street’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $884K | Buy |
162,200
+95,200
| +142% | +$534K | ﹤0.01% | 6791 |
|
|
2025
Q4 | $469K | Sell |
67,000
-24,200
| -27% | -$189K | ﹤0.01% | 7844 |
|
|
2025
Q3 | $705K | Sell |
91,200
-223,600
| -71% | -$1.75M | ﹤0.01% | 7080 |
|
|
2025
Q2 | $2.74M | Buy |
314,800
+145,400
| +86% | +$1.05M | ﹤0.01% | 3909 |
|
|
2025
Q1 | $1.35M | Sell |
169,400
-381,700
| -69% | -$3.86M | ﹤0.01% | 5025 |
|
|
2024
Q4 | $5.01M | Buy |
551,100
+125,200
| +29% | +$1.21M | ﹤0.01% | 2657 |
|
|
2024
Q3 | $3.91M | Buy |
425,900
+250,400
| +143% | +$2.07M | ﹤0.01% | 3258 |
|
|
2024
Q2 | $1.72M | Sell |
175,500
-165,000
| -48% | -$2.01M | ﹤0.01% | 4762 |
|
|
2024
Q1 | $5.14M | Sell |
340,500
-170,300
| -33% | -$3.09M | ﹤0.01% | 2571 |
|
|
2023
Q4 | $11M | Buy |
510,800
+51,200
| +11% | +$945K | ﹤0.01% | 1845 |
|
|
2023
Q3 | $8.54M | Buy |
459,600
+236,000
| +106% | +$5.51M | ﹤0.01% | 1958 |
|
|
2023
Q2 | $5.66M | Sell |
223,600
-40,900
| -15% | -$1.03M | ﹤0.01% | 2567 |
|
|
2023
Q1 | $6.85M | Sell |
264,500
-312,600
| -54% | -$8.37M | ﹤0.01% | 2044 |
|
|
2022
Q4 | $13.6M | Sell |
577,100
-407,300
| -41% | -$11M | 0.01% | 1317 |
|
|
2022
Q3 | $25M | Sell |
984,400
-228,400
| -19% | -$8.01M | 0.01% | 897 |
|
|
2022
Q2 | $40.3M | Buy |
1,212,800
+89,200
| +8% | +$3.79M | 0.02% | 652 |
|
|
2022
Q1 | $81M | Buy |
1,123,600
+501,900
| +81% | +$36.2M | 0.03% | 475 |
|
|
2021
Q4 | $57.1M | Buy |
621,700
+212,500
| +52% | +$25.4M | 0.02% | 586 |
|
|
2021
Q3 | $51.9M | Sell |
409,200
-127,900
| -24% | -$18.6M | 0.02% | 588 |
|
|
2021
Q2 | $89.3M | Sell |
537,100
-135,900
| -20% | -$22M | 0.03% | 343 |
|
|
2021
Q1 | $122M | Buy |
673,000
+285,713
| +74% | +$66.3M | 0.06% | 220 |
|
|
2020
Q4 | $77.4M | Buy |
387,287
+36,187
| +10% | +$7.36M | 0.04% | 319 |
|
|
2020
Q3 | $77M | Buy |
351,100
+88,100
| +33% | +$18.7M | 0.05% | 276 |
|
|
2020
Q2 | $50.2M | Buy |
263,000
+30,300
| +13% | +$5.31M | 0.04% | 354 |
|
|
2020
Q1 | $36.1M | Buy |
232,700
+206,300
| +781% | +$24M | 0.04% | 302 |
|
|
2019
Q4 | $2.21M | Sell |
26,400
-8,600
| -25% | -$654K | ﹤0.01% | 1832 |
|
|
2019
Q3 | $2.37M | Sell |
35,000
-22,400
| -39% | -$1.47M | ﹤0.01% | 1624 |
|
|
2019
Q2 | $3.81M | Buy |
57,400
+42,000
| +273% | +$2.45M | 0.01% | 1275 |
|
|
2019
Q1 | $856K | Sell |
15,400
-1,100
| -7% | -$67.2K | ﹤0.01% | 3004 |
|
|
2018
Q4 | $818K | Sell |
16,500
-7,700
| -32% | -$471K | ﹤0.01% | 2851 |
|
|
2018
Q3 | $2.09M | Buy |
24,200
+19,900
| +463% | +$1.42M | ﹤0.01% | 1853 |
|
|
2018
Q2 | $250K | Buy |
+4,300
| New | +$210K | ﹤0.01% | 4329 |
|
Other funds holding TDOC
VPM
VCM
VC
Jane Street's TDOC Position: Q1 2026 in Review
Jane Street reduced its Teladoc Health (TDOC) stake by 97% in Q1 2026, selling an estimated $4.8M and leaving 24,789 shares worth $135K. The position accounts for ﹤0.01% of the portfolio, ranked #10467.
Jane Street first reported a position in TDOC in Q3 2016 and has held it in 32 quarters since. The position peaked at $108M in Q3 2021. 323 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.
- Jane Street held 24,789 shares of Teladoc Health worth $135K as of Q1 2026.
- Jane Street sold 855,025 Teladoc Health shares in Q1 2026, an estimated $4.8M.
- Teladoc Health made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #10467 holding.
- Jane Street first reported a position in Teladoc Health in Q3 2016 and has held it in 32 quarters since.
- Jane Street's Teladoc Health position peaked at $108M in Q3 2021.
- 323 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.